Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

STAAR Surgical sg&a expenses from 2010 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

STAAR Surgical SG&A Expenses 2010-2025 | STAA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

STAAR Surgical sg&a expenses from 2010 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Related Stocks
Company Name	Market Cap
McKesson (MCK)	$87.4B
Becton Dickinson (BDX)	$57.1B
Cardinal Health (CAH)	$32.5B
Straumann Holding AG (SAUHY)	$18.7B
Labcorp (LH)	$18.2B
Cooper (COO)	$15.9B
West Pharmaceutical Services (WST)	$14.6B
Align Technology (ALGN)	$12.5B
Henry Schein (HSIC)	$7.9B
Merit Medical Systems (MMSI)	$5.4B
Patterson (PDCO)	$2.8B
DENTSPLY SIRONA (XRAY)	$2.6B
CONMED (CNMD)	$1.5B
Pro-Dex (PDEX)	$198M
Lifevantage (LFVN)	$169M